Type 2 diabetes mellitus as a risk factor for intestinal resection in patients with superior mesenteric vein thrombosis

Liver International

Volumn 34, Issue 9, 2014, Pages 1314-1321

  Elkrief, Laure ^a   Corcos, Olivier ^b   Bruno, Onorina ^b   Larroque, Beatrice ^b   Rautou, Pierre Emmanuel ^a   Zekrini, Kamal ^a   Bretagnol, Frédéric ^b   Joly, Francisca ^b   Francoz, Claire ^a   Bondjemah, Vanessa ^b   Cazals Hatem, Dominique ^b   Boudaoud, Larbi ^b   De Raucourt, Emmanuelle ^b   Panis, Yves ^b   Goria, Odile ^c   Hillaire, Sophie ^d   Valla, Dominique ^a   Plessier, Aurélie ^a  

^a CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^b BEAUJON HOSPITAL   (France)

^c HÔPITAL CHARLES NICOLLE   (France)

^d FOCH HOSPITAL   (France)

Author keywords

Acute mesenteric ischaemia; Computed tomography; Diabetes mellitus; Mesenteric venous thrombosis; Portal vein thrombosis

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INTESTINE ISCHEMIA; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; MESENTERIC VEIN THROMBOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL CONTRACEPTIVE USE; RETROSPECTIVE STUDY; RISK FACTOR; SUPERIOR MESENTERIC VEIN; COMPLICATION; DIABETES MELLITUS, TYPE 2; INTESTINE; ISCHEMIA; MESENTERIC ISCHEMIA; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; RADIOGRAPHY;

ANTICOAGULANTS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTESTINES; ISCHEMIA; MALE; MESENTERIC ISCHEMIA; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84908243884     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12386     Document Type: Article

References (35)

1. Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med 2001; 345: 1683-8.
2. Plessier A, Rautou P-E, Valla D-C. Management of hepaticvascular diseases. J Hepatol 2012; 56(Suppl 1): S25-38.
3. Plessier A, Darwish-Murad S, Hernandez-Guerra M, et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospectivemulticenter follow-up study. Hepatology 2010; 51: 210-8.
4. Amitrano L, Guardascione MA, Scaglione M, et al. Prognosticfactors in noncirrhotic patients with splanchnicvein thromboses. Am J Gastroenterol 2007; 102: 2464-70.
5. Harward TR, Green D, Bergan JJ, Rizzo RJ, Yao JS. Mesentericvenous thrombosis. J Vasc Surg 1989; 9: 328-33.
6. Clavien PA, Huber O, Rohner A. Venous mesentericischaemia: conservative or surgical treatment? Lancet 1989; 2: 48.
7. Morasch MD, Ebaugh JL, Chiou AC, et al. Mesentericvenous thrombosis: a changing clinical entity. J Vasc Surg 2001; 34: 680-4.
8. Rhee RY, Gloviczki P, Mendonca CT, et al. Mesentericvenous thrombosis: still a lethal disease in the 1990s. J Vasc Surg 1994; 20: 688-97.
9. Abdu RA, Zakhour BJ, Dallis DJ. Mesenteric venousthrombosis-1911 to 1984. Surgery 1987; 101: 383-8.
10. Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization onanticoagulant therapy. Hepatology 2000; 32: 466-70.
11. Rajani R, Bj€ornsson E, Bergquist A, et al. The epidemiologyand clinical features of portal vein thrombosis: a multicentrestudy. Aliment Pharmacol Ther 2010; 32: 1154-62.
12. Acosta S, Alhadad A, Svensson P, Ekberg O. Epidemiology, risk and prognostic factors in mesenteric venousthrombosis. Br J Surg 2008; 95: 1245-51.
13. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascularmorbidity and mortality associated with the metabolicsyndrome. Diabetes Care 2001; 24: 683-9.
14. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolicsyndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United Statesadults. Circulation 2004; 110: 1245-50.
15. Goldhaber SZ, Grodstein F, Stampfer MJ, et al. A prospectivestudy of risk factors for pulmonary embolism inwomen. JAMA 1997; 277: 642-5.
16. Amitrano L, Brancaccio V, Guardascione MA, et al. Highprevalence of thrombophilic genotypes in patients withacute mesenteric vein thrombosis. Am J Gastroenterol 2001; 96: 146-9.
17. Ayala R, Grande S, Bustelos R, et al. Obesity is an independentrisk factor for pre-transplant portal vein thrombosisin liver recipients. BMC Gastroenterol 2012; 12: 114.
18. Acosta S, Ogren M, Sternby N-H, Bergqvist D, Bj€orck M. Mesenteric venous thrombosis with transmural intestinalinfarction: a population-based study. J Vasc Surg 2005; 41: 59-63.
19. Clavien PA, D€urig M, Harder F. Venous mesenteric infarction: a particular entity. Br J Surg 1988; 75: 252-5.
20. International Diabetes Federation. World Health OrganizationDefinition and diagnosis of diabetes mellitus and intermediatehyperglycemia. Geneve: WHO Internationaldiabetes federation, 2006.
21. WHO. Obesity and overweight [Internet]. WHO. Availableat http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed 1 March 2013.
22. Denninger MH, Cha€i{dotless}t Y, Casadevall N, et al. Cause of portalor hepatic venous thrombosis in adults: the role ofmultiple concurrent factors. Hepatology 2000; 31: 587-91.
23. Wiesner W, Khurana B, Ji H, Ros PR. CT of acute bowelischemia Radiology 2003; 226: 635-50.
24. Clavien PA, Huber O, Mirescu D, Rohner A. Contrastenhanced CT scan as a diagnostic procedure in mesentericischaemia due to mesenteric venous thrombosis. Br J Surg 1989; 76: 93-4.
25. Johnson CC, Baggenstoss AH. Mesenteric vascular occlusion; study of 99 cases of occlusion of veins. Proc StaffMeet Mayo Clin 1949; 24: 628-36.
26. Darwish Murad S, Plessier A, Hernandez-Guerra M, et al. Etiology, management, and outcome of the Budd-Chiarisyndrome. Ann Intern Med 2009; 151: 167-75.
27. Goldhaber SZ, Bounameaux H. Pulmonary embolism anddeep vein thrombosis. Lancet 2012; 379: 1835-46.
28. ObEpi-Roche. enquête épidémiologique de référence surl'évolution de l'obésité et du surpoids en France [Internet]. Available at http://www.roche.fr/fmfiles/re7199006/obepi2012/index.html. Accessed: 31 December 2012.
29. Fagrell B, J€orneskog G, Intaglietta M. Disturbed microvascularreactivity and shunting-a major cause for diabeticcomplications. Vasc Med 1999; 4: 125-7.
30. Klitzman B, Duling BR. Microvascular hematocrit and redcell flow in resting and contracting striated muscle. Am JPhysiol 1979; 237: H481-90.
31. Curd LH Jr, Conrad MC. Role of sympathetics in theresponse to acute venous occlusion. Am J Physiol 1977; 233: H264-8.
32. Grendell JH, Ockner RK. Mesenteric venous thrombosis. Gastroenterology 1982; 82: 358-72.
33. Sikuler E, Kravetz D, Groszmann RJ. Evolution of portalhypertension and mechanisms involved in its maintenancein a rat model. Am J Physiol 1985; 248: G618-25.
34. Colombato LA, Albillos A, Groszmann RJ. Temporal relationshipof peripheral vasodilatation, plasma volumeexpansion and the hyperdynamic circulatory state in portal-hypertensive rats. Hepatology 1992; 15: 323-8.
35. Soubrane O, Braillon A, Lin HC, Kleber G, Lebrec D. Hemodynamiceffects of calibrated stenosis of the superiormesenteric artery in conscious rats with portal vein stenosis. Hepatology 1992; 16: 1447-51.